4 h. ago Grey Market Buzz: Corona Remedies IPO Trades At 24% Premium On Day 1 Subscription

The grey market premium for the Corona Remedies IPO continues to indicate positive listing gains despite declining since the last few days.

Economics

4 h. ago IPO GMP: Wakefit vs Corona Remedies – Grey Market Trends On Day 1 Of Subscription

The current grey market trends suggests that the unlisted shares of Wakefit and Corona Remedies were trading at a premium of 2-25%.

Economics

7 h. ago Grey Market Buzz: Corona Remedies IPO Trades At 27% Premium On Day 1 Subscription

The grey market premium for the Corona Remedies IPO continues to indicate positive listing gains despite declining since the last few days.

Economics

8 h. ago Corona Remedies IPO Day One: Check Subscription Status, GMP, And Financials

Corona Remedies IPO was subscribed 0.11 times or 11% as of 10:33 a.m. on Monday.

Economics

11 h. ago Corona Remedies Vs Wakefit: Which IPO Should Investors Go With?

As two mainboard IPOs open today, which one is the better fit for a common investor?

Economics

49 h. ago Corona Remedies IPO: Anchor Book Raises Rs 195 Crore, Largely From Mutual Funds

The company has allotted 18.34 lakh shares to anchor investors at the upper end of the price band.

Events

4 d. ago Corona Remedies IPO GMP: Here's What Grey Market Trends Suggest Ahead Of Launch

The Corona Remedies IPO will open for subscription on December 8.

Economics